USPTO Patent for Hair Follicle Regeneration
Summary
The USPTO has granted Washington University a patent (US12582649B2) for compositions and methods for hair follicle regeneration using TRPV4 activating agents. The patent aims to treat hair loss conditions such as alopecia and telogen effluvium.
What changed
The United States Patent and Trademark Office (USPTO) has issued patent US12582649B2 to Washington University. This patent covers compositions and methods for treating hair loss and promoting hair growth by administering TRPV4 activating agents. The patent, filed under application number 18009050, has 22 claims and is classified under CPC codes related to pharmaceutical compositions and cosmetic preparations for hair growth.
This patent grant is primarily an intellectual property matter and does not impose direct compliance obligations on regulated entities. However, it signifies a new development in the therapeutic landscape for hair loss treatments. Companies operating in the pharmaceutical and cosmetic sectors, particularly those involved in R&D for hair growth products, should be aware of this patented technology, as it may impact future product development and market entry strategies.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and methods for hair follicle regeneration
Grant US12582649B2 Kind: B2 Mar 24, 2026
Assignee
Washington University
Inventors
Hongzhen Hu
Abstract
Among the various aspects of the present disclosure is the provision of compositions and methods for treating hair regeneration disorders or conditions such as hair loss or thinning. An aspect of the present disclosure provides for a method of treating hair loss, promoting hair growth, or treating hair loss, such as alopecia or telogen effluvium, comprising administering a TRPV4 activating agent to a subject.
CPC Classifications
A61K 31/4965 A61K 9/0014 A61K 8/494 A61K 8/4973 A61K 8/498 A61K 8/4986 A61K 31/352 A61K 31/558 A61K 31/6615 A61K 2300/00 A61P 17/14 A61Q 7/00
Filing Date
2021-06-03
Application No.
18009050
Claims
22
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.